Brown Advisory’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Hold |
19,930
| – | – | ﹤0.01% | 1323 |
|
|
2025
Q1 | $70.6K | Hold |
19,930
| – | – | ﹤0.01% | 1305 |
|
|
2024
Q4 | $75.3K | Sell |
19,930
-20
| -0.1% | -$76 | ﹤0.01% | 1321 |
|
|
2024
Q3 | $64.6K | Sell |
19,950
-11
| -0.1% | -$36 | ﹤0.01% | 1246 |
|
|
2024
Q2 | $37.9K | Hold |
19,961
| – | – | ﹤0.01% | 1218 |
|
|
2024
Q1 | $56.7K | Buy |
19,961
+6,500
| +48% | +$18.5K | ﹤0.01% | 1224 |
|
|
2023
Q4 | $198K | Hold |
13,461
| – | – | ﹤0.01% | 1164 |
|
|
2023
Q3 | $246K | Hold |
13,461
| – | – | ﹤0.01% | 1059 |
|
|
2023
Q2 | $290K | Sell |
13,461
-5,000
| -27% | -$108K | ﹤0.01% | 1019 |
|
|
2023
Q1 | $542K | Sell |
18,461
-14,980
| -45% | -$440K | ﹤0.01% | 894 |
|
|
2022
Q4 | $1.24M | Sell |
33,441
-10,000
| -23% | -$370K | ﹤0.01% | 700 |
|
|
2022
Q3 | $1.22M | Buy |
+43,441
| New | +$1.22M | ﹤0.01% | 667 |
|